a burgundy zine
August 13, 2020
Last week, the National Institutes of Health announced that AI technology is underway to aid physicians across the United States in the global war against COVID-19.
Recently, we spoke to NIBIB/NIH Director of Research Sciences Krishna Kandarpa, M.D., P.h.D. via email to learn more about the development of this technology and how it could impact the future of radiology.
August 5, 2020
Inactive ingredients are a common staple of prescription medications. Often, they’re pretty harmless additives, like water, salt, or table sugar.
But some inactive ingredients may not be so inactive after all. A press release published by the National Institutes of Health yesterday says some inactive ingredients display biological activity, including “inflammation-related properties.”
July 22, 2020
Despite the recent spike in coronavirus cases, a glimmer of hope shines in from two recent National Institutes of Health press releases.
First, the NIH says placentas lack major molecules used by COVID-19 to cause an infection. This may explain why it’s (thankfully) very rare to see fetuses and newborns contracting the virus from infected pregnant mothers.
Second, the first phase of an NIH-sponsored COVID-19 vaccine appears to safely generate an immune response in healthy adults.
May 18, 2020
Red speckles and poofy, majestical shapes that appear to be pulled straight from a fairy tale are most likely at the forefront of your mind when you think of mushrooms – or, perhaps, some colorful, swirly-whirly imagery and “hippie babble” come to mind.
But there’s far more to mushrooms than meets the eye. Mycelium, the vegetative part of fungi that forms during the hyphae growth stage of mushrooms, has piqued the interests of researchers around the globe.
In recent years, scientists have put mycelium under the microscope due to its physical strength and pharmacological properties. This has opened the floodgates for mycelia to serve as a natural construction compound for building houses or creating new medicines.